GLP-3 is a triple-agonist investigational peptide studied for metabolism, fat loss, and glucose regulation. It is intended for adults who have researched advanced metabolic peptides and want to pursue one inside a physician-supervised program with enhanced informed consent.
What it is
GLP-3 is a single peptide that acts on three receptors at once: GLP-1, GIP, and glucagon. The first two influence appetite and blood sugar handling, while the glucagon component is associated with energy expenditure and fat metabolism.
Combining all three targets in one molecule is the newest direction in metabolic peptide research. The intent behind a triple agonist is broader metabolic effect than dual or single agonists, which is also why careful, slow titration and close physician oversight matter.
What the research explores
Triple-agonist compounds in this class are being studied for weight reduction, fat loss, and glucose regulation. The research is earlier than for established single or dual agonists, and long-term data is still developing. Individual response varies and we do not promise specific outcomes. This compound is prescribed only after a physician reviews your health picture and you complete enhanced informed consent.
How Origins prescribes it
You order online, complete a short health questionnaire, and a licensed physician reviews your information within 24 hours. Because this is an investigational compound, you will also complete an enhanced informed consent step. If the protocol is a fit, your GLP-3 is compounded by a licensed US pharmacy and shipped to your door. If the physician decides it is not appropriate for you, you pay nothing and receive a full refund. A monthly subscribe and save option is available to keep supply and oversight on schedule at a lower price.
This peptide is not right for everyone. A physician reviews your history and any contraindications before prescribing and will adjust or decline the protocol based on your individual picture. Nothing here is intended to diagnose, treat, cure, or prevent any disease.




Reviews
There are no reviews yet.